About
Autologous, adoptive T-cell therapies
Areas of Focus
Categories
Stem Cell & Cellular TherapyBoston & New England
Clinical Trials (25)
View allTotal Trials
25
As Lead Sponsor
8
As Collaborator
17
Total Enrollment
5,469
By Phase
NA: 2PHASE2: 5PHASE3: 4PHASE1/PHASE2: 1PHASE1: 3
By Status
UNKNOWN: 7COMPLETED: 6RECRUITING: 5ENROLLING_BY_INVITATION: 2NOT_YET_RECRUITING: 2ACTIVE_NOT_RECRUITING: 1TERMINATED: 1WITHDRAWN: 1
Clinical Trials Pipeline25 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Today
Hover over trial bars to see details
Recent Trials
NCT06966440Collaborator
Adjuvant Pancreatic Therapy Guided by MRD
NARecruiting
856 participants
Started: Jun 1, 2025 · Completed: Jun 1, 2030
NCT06242418Collaborator
CtDNA in Adjuvant Chemotherapy of Stage III Colon Cancer (REVISE Trial)
PHASE2Recruiting
60 participants
Started: Mar 25, 2024 · Completed: Dec 31, 2026
NCT05479708Collaborator
ctDNA-based Minimal Residual Disease Detection for Resected Pancreatic Adenocarcinoma
N/AEnrolling by invitation
150 participants
Started: Aug 9, 2023 · Completed: Nov 30, 2025
NCT05699746Collaborator
CAPEOX vs Observation in Colorectal Cancer Patients With Positive MRD
PHASE3Not yet recruiting
38 participants
Started: Mar 31, 2023 · Completed: Dec 31, 2026
NCT05244798Collaborator
Sintilimab Plus NCT or NCRT Versus NCRT for ESCC
PHASE3Not yet recruiting
420 participants
Started: Nov 1, 2022 · Completed: Dec 31, 2026
Locations (1)
Headquarters
Natick, MA, United States
Map
Loading map...